Clinical features of acute-on-chronic liver failure induced by withdrawal of nucleos(t)ide analogues
ObjectiveTo investigate the clinical features of patients with hepatitis B virus-related acute-on-chronic liver failure (ACLF) induced by the withdrawal of nucleos(t)ide analogues (NAs). MethodsA retrospective analysis was performed for the clinical data of 865 patients who were admitted to The Firs...
Main Authors: | HU Gaofei, LI Xiaopeng, WU Zhenping |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2017-07-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8323 |
Similar Items
-
Criteria for withdrawal of nucleos(t)ide analogues and their clinical significance in treatment of chronic hepatitis B
by: CHEN Hemin, et al.
Published: (2016-07-01) -
The efficacy and safety of nucleos(t)ide analogues in the treatment of HBV-related acute-on-chronic liver failure: a meta-analysis
by: Yu Shi, et al.
Published: (2013-05-01) -
Clinical effect of nucleos(t)ide analogues in treatment of acute exacerbation of chronic hepatitis B
by: RUAN Jianwen
Published: (2019-06-01) -
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
by: Sang Kyung Jung, et al.
Published: (2015-03-01) -
Risk factors for recurrence after drug withdrawal in HBeAg-positive chronic hepatitis B patients completing pharmacotherapy with nucleos(t)ide analogues
by: HU Bobin, et al.
Published: (2016-05-01)